Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials


Effects of Psilocybin in Obsessive Compulsive Disorder


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05546658

Organisation Name: Johns Hopkins University

Overal Status: Recruiting

Start Date: November 28, 2022

Last Update: November 29, 2022

Lead Sponsor: Johns Hopkins University

Brief Summary: This study will test the feasibility, safety, and evidence for efficacy of psilocybin administration in participants with obsessive compulsive disorder (OCD). This will serve as a preliminary proof of concept study for future larger studies aimed to investigate the utility, cognitive mechanisms, and neural correlates of this intervention.

Conditions:
  • Obsessive-Compulsive Disorder


Total execution time in seconds: 0.29190993309021